@article{8e4f20d54db64d93b1b4d3431eb62d67,
title = "A comprehensive update on the problem of blood culture contamination and a discussion of methods for addressing the problem",
abstract = "In this review, we present a comprehensive discussion of matters related to the problem of blood culture contamination. Issues addressed include the scope and magnitude of the problem, the bacteria most often recognized as contaminants, the impact of blood culture contamination on clinical microbiology laboratory function, the economic and clinical ramifications of contamination, and, perhaps most importantly, a systematic discussion of solutions to the problem. We conclude by providing a series of unanswered questions that pertain to this important issue.",
keywords = "Blood, Contamination, Culture",
author = "Doern, {Gary V.} and Carroll, {Karen C.} and Diekema, {Daniel J.} and Garey, {Kevin W.} and Rupp, {Mark E.} and Weinstein, {Melvin P.} and Sextong, {Daniel J.}",
note = "Funding Information: We disclose the following associations: G.V.D., consultant (Magnolia Medical Technologies) and honoraria (UpToDate); K.C.C., research support (GenMark, Singulex and Accelerate); D.J.D., research support (bioM{\'e}rieux); K.W.G., research support (Magnolia Medical Technologies, Merck & Co, Summit Therapeutics, and Tetraphase); M.E.R., research support (Magnolia Medical Technologies, ContraFect, and XBioTech), consultant (3M, Citius, Telefex/Arrow, and Ariste), advisory panel (3M), and webinar participant (Magnolia Medical Technologies); M.P.W., research support (Beckman-Coulter, JMI Laboratories, and the NJ Department of Health), speaker{\textquoteright}s honoraria (Beckman-Coulter), and consultant (SeLux Diagnostics and T2 Biosystems); D.J.S., medical advisory board (Magnolia Medical Technologies), stock ownership (Magnolia Medical Technologies), honoraria (UpToDate), research support (Centers for Disease Control and Prevention, the Duke-UNC Prevention Epicenter, and the National Football League), and consultant (Johnson & Johnson). Each of the authors was the recipient of an unrestricted educational grant from Magnolia Medical Technologies in support of this review. Funding Information: We appreciate the critical evaluation of the manuscript and helpful suggestions for revision by Christopher D. Doern, Director, Clinical Microbiology Laboratories, Medical College of Virginia, Richmond, VA. We disclose the following associations: G.V.D., consultant (Magnolia Medical Technologies) and honoraria (UpToDate); K.C.C., research support (GenMark, Singulex and Accelerate); D.J.D., research support (bioM{\'e}rieux); K.W.G., research support (Magnolia Medical Technologies, Merck & Co, Summit Therapeutics, and Tetraphase); M.E.R., research support (Magnolia Medical Technologies, ContraFect, and XBioTech), consultant (3M, Citius, Telefex/Arrow, and Ariste), advisory panel (3M), and webinar participant (Magnolia Medical Technologies); M.P.W., research support (Beckman- Coulter, JMI Laboratories, and the NJ Department of Health), speaker{\textquoteright}s honoraria (Beckman-Coulter), and consultant (SeLux Diagnostics and T2 Biosystems); D.J.S., medical advisory board (Magnolia Medical Technologies), stock ownership (Magnolia Medical Technologies), honoraria (UpToDate), research support (Centers for Disease Control and Prevention, the Duke-UNC Prevention Epicenter, and the National Football League), and consultant (Johnson & Johnson). Each of the authors was the recipient of an unrestricted educational grant from Magnolia Medical Technologies in support of this review. Publisher Copyright: {\textcopyright} 2019, American Society for Microbiology. All rights reserved.",
year = "2020",
month = jan,
doi = "10.1128/CMR.00009-19",
language = "English (US)",
volume = "33",
journal = "Clinical Microbiology Reviews",
issn = "0893-8512",
publisher = "American Society for Microbiology",
number = "1",
}